Difficulty: Medium
Average Score: 92%
Practice
Suxamethonium
Correct answer
D
Rationale
In the context of CNS Stimulants Drugs Pharmacology, Suxamethonium, also known as succinylcholine, is a depolarizing neuromuscular blocking agent used for rapid muscle relaxation during anesthesia. The correct answer, option D, stating that Suxamethonium should not be administered to burn patients after 24 hours, is accurate due to the risk of hyperkalemia in burn patients, especially after the initial phase of injury.
Option A, stating that Suxamethonium is a non-depolarizing neuromuscular blocking agent, is incorrect as Suxamethonium is a depolarizing agent that initially causes muscle fasciculations before inducing paralysis. Option B, claiming that Suxamethonium is contraindicated in all eye operations, is incorrect as it can be used in ophthalmic surgeries without posing significant risks. Option C, suggesting that Suxamethonium stimulates cardiac muscarinic receptors and autonomic ganglia, is incorrect as its effects are primarily at the neuromuscular junction.
Understanding the pharmacological properties and appropriate clinical use of Suxamethonium is crucial for healthcare professionals, especially anesthetists and critical care providers. It is essential to be aware of contraindications and potential complications associated with its administration in specific patient populations, such as burn patients, to ensure safe and effective pharmacological management.
Option A, stating that Suxamethonium is a non-depolarizing neuromuscular blocking agent, is incorrect as Suxamethonium is a depolarizing agent that initially causes muscle fasciculations before inducing paralysis. Option B, claiming that Suxamethonium is contraindicated in all eye operations, is incorrect as it can be used in ophthalmic surgeries without posing significant risks. Option C, suggesting that Suxamethonium stimulates cardiac muscarinic receptors and autonomic ganglia, is incorrect as its effects are primarily at the neuromuscular junction.
Understanding the pharmacological properties and appropriate clinical use of Suxamethonium is crucial for healthcare professionals, especially anesthetists and critical care providers. It is essential to be aware of contraindications and potential complications associated with its administration in specific patient populations, such as burn patients, to ensure safe and effective pharmacological management.